Apr 15 |
Biohaven stock slides 15% amid data presentations
|
Apr 13 |
Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates
|
Apr 4 |
LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside?
|
Mar 20 |
Bullish Biohaven Insiders Loaded Up On US$23.8m Of Stock
|
Feb 29 |
Biohaven GAAP EPS of -$1.81 misses by $0.40
|
Feb 29 |
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
|
Feb 28 |
Biohaven's Bounce Back: A Missed Call Turns Bullish (Rating Upgrade)
|
Feb 18 |
A Look At The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)
|
Feb 16 |
RBC Capital starts Biohaven at outperform, cites epilepsy drug
|
Feb 7 |
UBS starts Biohaven at buy, cites diverse pipeline
|